RE:RE:The Biogen Saga continues key line from the article: "on the basis of current evidence at a FDA advisory committee meeting late last year"
I find it a bit odd that they would publish a potentially outdated assessment. Isn't the FDA currently reviewing some updated data from Biogen as a part of the extended review agreement?
I'm not saying these reviewers have any sort of agenda other than providing the best scientific advice possible, but it seems odd that they would publish an article based on last year's news (that everyone was already following closely).